3Sugabara K, Yamada Y, Hirata Y, et al. Soluble and men brane isoform of Fas/CD95 in fresh adult T-cell leukemia (ALT) cells and ALT-cell lines[J]. Int J Cancer, 1997,72:126 - 132.
4Traver D, Akasbi K, WeissmaulL,et al. Mice defective in two apoptos ins pathwys in the myeloid liueage develop acute myeloblastic leukemia [ J Immunity, 1998,9:47 - 57.
5Munker R, Mid is G, Owen SL, et al. Soluable Fas (CD95) is not elevated in the serum of patients with myeloid leukemia in yeloproliferative and in yelodysplastic syudromes[ J ]. Leukemia, 1996,10:1531 - 1533.
6Sotomayor E M, DinapofiM R, Calderon C, et al. Decreased macrophagemediated cytotoxicity in mammary-tumol-bearing in ice is related to alteration of oitric-oxide preoduction and/or release[ J ]. int J Cancer, 1995,60(s) :660 - 667.
7Shami PJ, Moore JO, Gockerman JP, et al. Nitric oxide modulation of the growth and differentiation of freshly isolated acute nonlymphocytic leukemia cells. Leuk Res, 1995, 19: 527-533.
8Zhao HX, Dugas N, Mathiot C, et al. B-cell chronic lymphocytic leukemia cells express a functional inducible nitric oxide synthase displaying anti-apoptotic activity. Blood, 1998, 92: 1031-1034.
9Tetsuo K,Miho A,Keiko H,et al.Apoptosis of human leukemia cells induced by artepillin can active ingredient of Brazilian proplis[J].Anticancer Res,2001,21(6):221-228.
10Secchiero P,Milani D,Gonelli A.Tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) and TNF-alpha promote the NFkappaB-dependent maturation of normal and leukemic myeloid cells[J].J Leukoc Bio1,2003,74(2):223-232.
